Proxima Bio
Melbourne, AU · 3 known investors
Find your way into Proxima Bio
Proxima Bio is an early-stage biotechnology company developing protein degradation technology to target previously undruggable proteins for treatment of autoimmune conditions and cancers. The company is spun out of WEHI (Walter and Eliza Hall Institute) and based in Melbourne, Australia.
Founders & leadership
J
JaseCo-founder
J
JonCo-founder
JM
John McFarlandExecutive
ZC
Zachary CarpenterNamed on SEC filing
Board
JP
AG
Alex GasnerBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$91.5M disclosed across 1 of 2 rounds · 2024–2026
▶$91.5MraisedJun 2026 · 11 investors · Other Health CareRule 506(b)
▶$91.5MraisedJun 2026 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jason PontinDirector
- Zachary CarpenterExecutive Officer, Director
- Alex GasnerDirector
- John McFarlandExecutive Officer
- Offering amount
- $91.5M
- Amount sold
- $91.5M
- Minimum investment
- $1
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Proxima Bio do?
- Proxima Bio is an early-stage biotechnology company developing protein degradation technology to target previously undruggable proteins for treatment of autoimmune conditions and cancers. The company is spun out of WEHI (Walter and Eliza Hall Institute) and based in Melbourne, Australia.
- Who founded Proxima Bio?
- Proxima Bio was founded by Jase, Jon.
- Who are Proxima Bio's investors?
- Proxima Bio's investors include Tenmile, Tin Alley Ventures, DCVC (Data Collective).
- How much funding has Proxima Bio raised?
- Proxima Bio has disclosed $91.5M raised across 1 of its 2 known rounds.
- Where is Proxima Bio headquartered?
- Proxima Bio is headquartered in Melbourne, AU.